Description

(3aS)-1,2,3a,4,4aβ,6,7,9,13bβ,13cβ-Decahydro-7β-hydroxy-9α-(hydroxymethyl)-11-methoxy-5,12-dimethyl-4α,6α-methano-5H-benz[h]oxazolo[3,2-a]pyrazino[3,2,1-de][1,5]naphthyridine-10,13-dione is a complex, high-purity alkaloid derivative with a unique fused polycyclic structure. This compound is of significant interest for its potential as a key intermediate or reference standard in advanced pharmaceutical research and development. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of complex alkaloid-based drug candidates.
• Reference Standard: Used for analytical method development, validation, and quality control in pharmaceutical laboratories.
• Medicinal Chemistry Research: A valuable scaffold for structure-activity relationship (SAR) studies and the discovery of new bioactive molecules.
• Academic Research: Employed in chemical and pharmacological studies investigating novel heterocyclic compounds.
• Process Development: Used in scaling up and optimizing synthetic routes for complex organic molecules.

Basic Information

Item	Details
Product Name	(3aS)-1,2,3a,4,4aβ,6,7,9,13bβ,13cβ-Decahydro-7β-hydroxy-9α-(hydroxymethyl)-11-methoxy-5,12-dimethyl-4α,6α-methano-5H-benz[h]oxazolo[3,2-a]pyrazino[3,2,1-de][1,5]naphthyridine-10,13-dione
CAS No.	54913-26-7
Molecular Formula	C24H28N2O6
Molecular Weight	440.49 g/mol
Synonyms	7β-Hydroxy-9α-(hydroxymethyl)-11-methoxy-5,12-dimethyl-4α,6α-methano-5H-benz[h]oxazolo[3,2-a]pyrazino[3,2,1-de][1,5]naphthyridine-10,13-dione; Decahydro-7β-hydroxy-9α-(hydroxymethyl)-11-methoxy-5,12-dimethyl-4α,6α-methano-5H-benz[h]oxazolo[3,2-a]pyrazino[3,2,1-de][1,5]naphthyridine-10,13-dione; Alkaloid derivative 54913-26-7; Complex fused oxazolo-pyrazino-naphthyridine dione.
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. We provide comprehensive analytical data including HPLC purity, identity confirmation (IR, NMR), and impurity profiling. Certificates of Analysis (COA) are available upon request, detailing batch-specific results. Production can be aligned with cGMP guidelines for advanced pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry environment. This compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.